Biopharm Co. Stockholders Challenge Director Pay In Del. Suit
A stockholder of gene therapy company Adverum Biotechnologies Inc. has sued its current and past directors on Adverum's behalf in Delaware's Court of Chancery, seeking to recover allegedly "grossly excessive" compensation...To view the full article, register now.
Already a subscriber? Click here to view full article